News

  July 28, 2010

AMRI to Announce Second Quarter 2010 Results

Register for Webcast

Albany , NY (July 28, 2010)— AMRI (NASDAQ: AMRI ) today announced it will issue second quarter financial results before market open on Wednesday, August 4, 2010.

AMRI will host a conference call to discuss the results on Wednesday, August 4, 2010 at 10 a.m. EDT. The conference call can be accessed by dialing 888-359-3612 (domestic calls) or 719-785-1752 (international calls) at 9:45 a.m. EDT and entering passcode 7254813. The webcast will be available live via the Internet and can be accessed on the company's website at www.amriglobal.com .

Replays of the webcast can also be accessed for up to 90 days after the call via the investor area of the company's website at www.amriglobal.com/investor_relations/ .

Founded in 1991, Albany Molecular Research, Inc. (AMRI) provides scientific services, products and technologies focused on improving the quality of life. AMRI works on drug discovery and development projects and conducts manufacturing of active ingredients and pharmaceutical intermediates for many of the world's leading healthcare companies. As an additional value added service to its customers, the company is also investing in R&D in order to expand its contract services and to identify novel early stage drug candidates with the goal to outlicense to a strategic partner. With locations in the United States , Europe, and Asia , AMRI provides customers with a wide range of services, technologies and cost models.

Contacts:
Investor – Peter Jerome, Director of Investor Relations, 518-512-2220

Media – Andrea Schulz, Director of Corporate Communications, 518-512-2226